Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
.jpg)
August 30, 2022
Only one week remains before the start of virtual CEU 2022, September 8-10. Join us to discover the latest innovative practices in endocrinology diagnosis and treatment. This is a must-attend event for all endocrinologists, and it features 42 sessions covering nine of the most crucial topics in hormone health. CEU is certified for 28 AMA PRA Category 1 Credits™ and AAPA Category 1 CME Credits and Nursing Contact Hours. Register Now!
August 24, 2022
Endocrine Board Review (EBR) will equip you with the knowledge to excel in your board certification exam. Join us on September 16-18 for an online Q&A session with experts, who will provide in-depth analysis behind their recommendations. Registration includes the Endocrine Board Review 14th Edition (now available for ordering) as well as access to on-demand mock exam sessions starting August 15 at 9:00 AM. Register now!
August 30, 2022
Save up to 40% off membership when you join today and access member benefits from now until December 31, 2023—you don’t want to miss this opportunity! Hurry, this offer ends September 30.
August 10, 2022
Sign up to auto-renew your membership to stay connected to our global community of 18,000 endocrine researchers and practitioners improving human health worldwide. If you sign up for Auto Renewal by September 13, you will be entered into a drawing to receive a complimentary registration for ENDO 2023.
August 19, 2022
We celebrate the historic signing of the Inflation Reduction Act into law, which includes a provision to cap insulin costs for Medicare beneficiaries. We will keep working to ensure all people with diabetes who rely on insulin can benefit from lower out-of-pocket costs.
Need more info?
Learn more about the advantages of membership
August 29, 2022
The Endocrine Society has hired Steven R. Meyers, PhD—an association executive with more than a decade of experience in strategic thinking and transforming and expanding operations—to serve as its Chief Strategy Officer.
August 16, 2022
The Endocrine Society is elated about President Biden signing into law the Inflation Reduction Act, which includes meaningful measures to make insulin more affordable.
August 07, 2022
The Endocrine Society cheered the Senate’s passage of the Inflation Reduction Act, including meaningful measures to make insulin more affordable.
August 30, 2022
We aim to determine the clinical utility of the growth hormone-releasing peptide-2 test in patients with hypothalamic-pituitary disorders, particularly for adrenal insufficiency concomitant with growth hormone deficiency.
August 30, 2022
We assess whether oral glucose tolerance test (OGTT) measures could serve as FPIR alternatives in their ability to predict T1D in autoantibody positive (Aab+) subjects.
August 30, 2022
We hypothesize that monocarboxylate transporter 8 (MCT8) and IGSF1 may interact and that loss of IGSF1 may alter MCT8 cellular trafficking and/or function, contributing to central hypothyroidism in IGSF1 deficiency.
